NEW PRODUCT: Epkinly for treatment of relapsed or refractory diffuse large B-cell lymphoma Get the info you need on this new product, part of our drug news roundup for May. Daily marijuana use outpaces daily drinking in the U.S.Alcohol is still more widely used, but 2022 was the first time this intensive level of marijuana use overtook daily and near-daily drinking. ‘The WhatsApp of healthcare’: Lumeca Messages lets providers send secure messages It’s 2024—why are healthcare providers still relying on faxes and phone messages to communicate? In England, pharmacists are gaining power A small revolution is taking place across the Atlantic. Helping healthcare pros screen for gender-based violence New research aims to help fulfil recommendations made by commission that examined the 2020 mass shooting in Nova Scotia. Which is better for endometriosis-related pain: oral contraceptives or long-acting progestogens? Study examines the efficacy of combined oral contraceptives versus long-acting progestogens for preventing recurrence of pain after surgery for endometriosis. N.S. doctors say not enough physicians to teach at new Cape Breton medical school Dr. Stacy MacDonald says the university is rushing the process. NEW PRODUCT: Wezlana and Wezlana I.V. for plaque psoriasis and more Get the info you need on this new product, part of our drug news roundup for May. NEW PRODUCT: Ranopto for neovascular age-related macular degeneration and more Get the info you need on this new product, part of our drug news roundup for May. NEW PRODUCT: Jamteki for chronic moderate to severe plaque psoriasis, active psoriatic arthritis Get the info you need on this new product, part of our drug news roundup for May. First Previous 116 117 118 119 120 Next Last
